Excess zinc in muscles contributes to wasting syndrome in cancer: Discovery could lead to the development of treatments for a debilitating condition implicated in 30 percent of all cancer deaths

It’s estimated that nearly one-third of all cancer deaths are caused not by the cancer itself but by cachexia —

What would help or hinder patient participation in mitochondrial disease clinical trials? Patient-centric perspective offers key insights into upcoming treatment studies

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study